Head-To-Head Survey: CapsoVision (CV) versus Its Competitors

CapsoVision (NASDAQ:CV – Get Free Report) is one of 511 publicly-traded companies in the “Healthcare Equipment & Supplies” industry, but how does it compare to its peers? We will compare CapsoVision to related companies based on the strength of its institutional ownership, valuation, analyst recommendations, earnings, profitability, dividends and risk.

Volatility and Risk

CapsoVision has a beta of -2.34, meaning that its stock price is 334% less volatile than the S&P 500. Comparatively, CapsoVision’s peers have a beta of 2.58, meaning that their average stock price is 158% more volatile than the S&P 500.

Institutional & Insider Ownership

40.5% of shares of all “Healthcare Equipment & Supplies” companies are held by institutional investors. 2.3% of CapsoVision shares are held by insiders. Comparatively, 14.9% of shares of all “Healthcare Equipment & Supplies” companies are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Valuation & Earnings

This table compares CapsoVision and its peers gross revenue, earnings per share (EPS) and valuation.

Gross Revenue Net Income Price/Earnings Ratio
CapsoVision $13.55 million -$25.32 million -13.77
CapsoVision Competitors $1.89 billion $135.83 million 5.73

CapsoVision’s peers have higher revenue and earnings than CapsoVision. CapsoVision is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.

Analyst Recommendations

This is a summary of recent recommendations and price targets for CapsoVision and its peers, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
CapsoVision 1 1 2 0 2.25
CapsoVision Competitors 4311 10599 18393 838 2.46

CapsoVision presently has a consensus price target of $9.50, indicating a potential upside of 46.83%. As a group, “Healthcare Equipment & Supplies” companies have a potential upside of 22.19%. Given CapsoVision’s higher probable upside, equities research analysts plainly believe CapsoVision is more favorable than its peers.

Profitability

This table compares CapsoVision and its peers’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
CapsoVision -210.09% -188.10% -139.99%
CapsoVision Competitors -270.28% -155.47% -22.38%

Summary

CapsoVision peers beat CapsoVision on 11 of the 13 factors compared.

CapsoVision Company Profile

(Get Free Report)

CapsoVision develops medical technology for capsule endoscopy, a method of examining the digestive tract using a swallowable camera. Its products are designed to help clinicians visualize the small intestine as part of diagnostic evaluation. The company’s CapsoCam Plus system uses a swallowable capsule with multiple cameras to capture panoramic images as it moves through the small intestine. Images are stored in the capsule and later retrieved for review using the company’s supporting hardware and software.

Receive News & Ratings for CapsoVision Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CapsoVision and related companies with MarketBeat.com's FREE daily email newsletter.